Onspira Therapeutics
-
Blackstone Life Sciences Commits Up To $300 Million to Malvern-Based Uniquity Bio
Malvern-based Uniquity Bio is emerging from stealth mode after getting up to $300 million from Massachusetts-based private equity firm Blackstone Life Sciences, writes John George…
-
Malvern’s Onspira Therapeutics Raises $1 Million in Private Stock Sale
Malvern’s Onspira Therapeutics, which develops treatments for patients with rare pulmonary diseases, has raised $1 million from a private stock sale, writes John George for…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
